Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adult Opioid-Dependence”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Early research (Phase 1)Study completedNCT01820442
What this trial is testing

Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients

Who this might be right for
Opioid DependenceBuprenorphine Withdrawal Syndrome
USWM, LLC (dba US WorldMeds) 30
Not applicableUnknownNCT00182598
What this trial is testing

Applying Web Technology to Buprenorphine Treatment

Who this might be right for
Adult Opioid-Dependence
National Development and Research Institutes, Inc. 90
Early research (Phase 1)Study completedNCT01558934
What this trial is testing

Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients

Who this might be right for
Opioid DependenceMethadone Withdrawal Syndrome
USWM, LLC (dba US WorldMeds) 6
Large-scale testing (Phase 3)Study completedNCT02180659
What this trial is testing

Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants

Who this might be right for
Opioid Dependence
Titan Pharmaceuticals 177
Large-scale testing (Phase 3)Study completedNCT01052662
What this trial is testing

Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults

Who this might be right for
Opioid Dependence
University of Massachusetts, Worcester 87
Not applicableNot Yet RecruitingNCT07661823
What this trial is testing

QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (Quantum AI/AGI Agency a/k/a AI City Hall Project - UPSTO App Nos. 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428, 64/125,360)

Who this might be right for
Asperger's DisorderAsperger DisorderAutism Disorder+41 more
Veterans Recovery Network Inc. 1,000,000
Large-scale testing (Phase 3)Study completedNCT02537574
What this trial is testing

Naltrexone for Use in Conjunction With Buprenorphine in Adults With Opioid Use Disorder Prior to First Dose of VIVITROL® (Naltrexone for Extended-Release Injectable Suspension)

Who this might be right for
Opioid Use Disorder
Alkermes, Inc. 380
Large-scale testing (Phase 3)UnknownNCT03394911
What this trial is testing

Healthy Adult Male Facial Skin Surface Lipid Pheromone p.o. to Treat Opioid Addiction

Who this might be right for
Opioid AddictionOpioid Abuse, Continuous UseOpioid Use+7 more
Bubba Nicholson 500
Post-approval studies (Phase 4)WithdrawnNCT01015066
What this trial is testing

Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents

Who this might be right for
Opiate Addiction
State University of New York at Buffalo
Not applicableStudy completedNCT02718352
What this trial is testing

A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence

Who this might be right for
Opioid Dependence
Yale University 8
Early research (Phase 1)Study completedNCT00800319
What this trial is testing

ALK33-001: A Study of RDC-0313 Administered to Healthy Adults

Who this might be right for
Alcohol Dependence
Alkermes, Inc. 16
Large-scale testing (Phase 3)Study completedNCT02651584
What this trial is testing

Clinical Trial of CAM2038, Long-acting Subcutaneous Buprenorphine Injections for Treatment of Patients With Opioid Dependence

Who this might be right for
Opioid Use Disorders
Braeburn Pharmaceuticals 428
Not applicableStudy completedNCT03791645
What this trial is testing

Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction

Who this might be right for
Opioid UseOpioid-use DisorderSubstance Use Disorders
Ohio State University 61
Not applicableStudy completedNCT05074524
What this trial is testing

Repetitive Transcranial Magnetic Stimulation to Reduce Heroin Cravings

Who this might be right for
Opioid-use DisorderHeroin AbuseCraving+1 more
University of Nevada, Las Vegas 24
Testing effectiveness (Phase 2)Study completedNCT01218984
What this trial is testing

ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids

Who this might be right for
Opiate Dependence
Alkermes, Inc. 27
Large-scale testing (Phase 3)Study completedNCT00678418
What this trial is testing

ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence

Who this might be right for
Opiate Dependence
Alkermes, Inc. 250
Large-scale testing (Phase 3)Study completedNCT00061087
What this trial is testing

Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1

Who this might be right for
ADHDOpioid-Related DisordersCocaine Dependence
New York State Psychiatric Institute 115
Large-scale testing (Phase 3)Ended earlyNCT00156936
What this trial is testing

ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])

Who this might be right for
AlcoholismOpiate Dependence
Alkermes, Inc. 108
Large-scale testing (Phase 3)Study completedNCT01908842
What this trial is testing

Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults

Who this might be right for
Opioid Dependence, on Agonist Therapy
Orexo AB 759
Not applicableStudy completedNCT04015115
What this trial is testing

Youth Opioid Recovery Support: Improving Care Systems

Who this might be right for
Opioid-Related Disorders
University of Maryland, Baltimore 44
Next Page